2004 Korean hypertension treatment guideline and its perspective

Korean Circulation Journal

Volumn 36, Issue 6, 2006, Pages 405-410

  Park, Jeong Bae ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Guideline; Hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; FOLLOW UP; HUMAN; HYPERTENSION; LIFESTYLE; PHYSICIAN; PRACTICE GUIDELINE; PREVALENCE; REVIEW;

EID: 33746217508     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2006.36.6.405     Document Type: Review

References (18)

1. Kim HC, Nam CM, Jee SH, Suh I. Comparison of blood pressure-associated risk of intracerebral hemorrhage and subarachnoid hemorrhage: Korea Medical Insurance Corporation study. Hypertension 2005;46:393-7.
2. Jones DW, Kim JS, Kim SJ, Hong YP. Hypertension awareness, treatment and control rates for an Asian population: results from a national survey in Korea. Ethn Health 1996;1:269-73.
3. Jo I, Ahn Y, Lee J, Shin KR, Lee HK, Shin C. Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Ansan study. J Hypertens 2001;19:1523-32.
4. Korea Institute for Health and Social Affairs. 2001 National Health and Nutrition Survery report; 2002.
5. Williams B, Poulter NR, Brown MJ, et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004;18:139-85.
6. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001;358:1682-6.
7. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001;345:1291-7.
8. Bae JM, Ahn YO. A nested case-control study on the high-normal blood pressure as a risk factor of hypertension in Korean middle-aged men. J Korean Med Sci 2002;17:328-36.
9. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13.
10. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
11. Cifkova R, Erdine S, Fagard R, et al. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 2003;21:1779-86.
12. Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-92.
13. Williams B, Poulter NR, Brown MJ, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004;328:634-40.
14. Sung J, Choi JH, On YK, et al. Study of compliance to antihypertensive medication in Korean hypertensive patients using medication event monitoring system. Korean Circ J 2005;35:821-6.
15. Oh SW, Shin SA, Yun YH, Yoo T, Huh BY. Cut-off point of BMI and obesity-related comorbidities and mortality in middle-aged Koreans. Obes Res 2004;12:2031-40.
16. Lim S, Park KS, Lee HK, Cho SI. Changes in the characteristics of metabolic syndrome in Korea over the period 1998-2001 as determined by Korean National Health and Nutrition Examination Surveys. Diabetes Care 2005;28:1810-2.
17. Yoo TW, Sung KC, Kim YC, et al. The relationship of the hypertension, insulin resistance, and metabolic syndrome in the serum uric acid level. Korean Circ J 2004;34:874-82.
18. WHO Western Pacific Region, International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney, Australia: Health Communications Australia; 2000. p. 15-21.